Scientists at Stanford Medicine have discovered a tiny naturally occurring molecule that appears to do something millions of people have been waiting for: suppress appetite and drive fat loss the way Ozempic does, but without the nausea, constipation, and muscle loss that make the popular drug so difficult for many people to tolerate. The molecule, called BRP, is a small peptide made up of just 12 amino acids, and it was identified using an AI tool the team built specifically to scan all 20,000 human protein-coding genes and predict which molecules might function as appetite-regulating hormones in the brain. In animal studies, a single injection before a meal reduced food intake by up to 50 percent within an hour, while daily injections over two weeks in obese mice produced significant fat loss, improved blood sugar control, and better insulin tolerance, all while untreated animals simply continued to gain weight over the same period.
What makes BRP especially promising is where it acts in the body. While Ozempic targets receptors scattered throughout the gut, pancreas, and other tissues, which is precisely what causes the wide range of unpleasant side effects that lead many users to stop taking it, BRP appears to work specifically inside the hypothalamus, the part of the brain that directly governs appetite and metabolism. Animals in the studies showed no changes in movement, water intake, anxiety, or digestion, suggesting a far cleaner biological profile than anything currently available. The senior researcher behind the discovery has already co-founded a company and announced plans to begin human clinical trials in the near future, and the findings have been published in the journal Nature. Scientists say BRP opens a genuinely new and targeted direction in the long search for weight loss treatments that are both powerfully effective and much easier on the body than what exists today.
Source: https://www.sciencedaily.com/releases/2026/04/260412221946.htm
